Many people with diabetes have the earliest stage of diabetic retinopathy, called mild nonproliferative diabetic retinopathy (NPDR), without even knowing it, according to the American Academy of ...

Two large NIH-funded clinical studies have shown promising results that laser photocoagulation therapy prevents vision loss in patients with diabetic retinopathy. Results of the Diabetic Retinopathy ...

Eye injections are the only medication currently available to treat diabetes-related retinopathy. Modern eye injections are not painful and don’t cause many side effects. Diabetic retinopathy affects ...

Retinopathy refers to conditions or damage affecting the retina. Without treatment, it can cause blindness. Hypertensive retinopathy results from high blood pressure, while diabetic retinopathy is a ...

Treating people in the early stages of diabetes-related eye disease may help slow the progression of the condition, but a new study also suggests that it can’t help prevent vision loss in the future.

Proliferative diabetic retinopathy (PDR) is the advanced stage of diabetic retinopathy. It involves the development of abnormal retinal blood vessels. The vessels may leak blood and fluid into the ...

REGENXBIO Inc. announced additional positive interim data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular ...

Diabetic retinopathy involves damage to the eye’s retina due to high blood sugar levels in the body. It is a common complication of diabetes, affecting millions of people with both type 1 and type 2 ...

A four-year clinical study has found that while early treatment of diabetes-related eye disease using anti-vascular endothelial growth factor (anti-VEGF; aflibercept) slowed progression to severe ...

Please provide your email address to receive an email when new articles are posted on . “Therefore, expanding the screening area of DR and carrying out targeted prevention and treatment of blindness ...

Maria Grant, MD, along with her team at the UAB Heersink School of Medicine Department of Ophthalmology and Visual Sciences teamed up with researchers from the University of Florida College of ...

Please provide your email address to receive an email when new articles are posted on . Ocuphire Pharma reported oral APX3330 for the treatment of diabetic retinopathy failed to meet the primary ...